To observe the effects of small interfering RNA (siRNA)-targeting bone morphogenetic protein (BMP)-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells and its mechanism. Three siRNAs-targeting BMP-2 gene were synthesized. There were six groups including group I (non-transfected cells), group II (only liposome-transfected cells), group III (non-specific siRNA-transfected cells) and groups IV-VI (siRNA-A, siRNA-B and siRNA-C-targeting BMP-2 transfected cells, respectively). SMMC7721 cells were instantaneously transfected using lipofectamine method. The levels of mRNA and protein of BMP-2 in cells were determined with reverse transcription-PCR and western blotting. The abilities of migration and invasion of transfected cells were assessed using scratch test and in vitro invasion assay, respectively. The protein levels of p-ERK, p-JNK and p-p38 and the protein levels of MMP-2 and MMP-9 were evaluated with western blot 48 h after siRNA-B-targeting BMP-2 was transfected into liver cancer SMMC7721 cells. Expression of mRNA and protein of BMP-2 in groups IV-VI were significantly inhibited, especially in group V. Cell scratch width was significantly greater in group V than in group I and III (Po0.01). In vitro invasion assay suggested that the number of invasion of cells was significantly lower in group V than in group I and III (Po0.05). Western blot indicated that the level of p-ERK was significantly decreased (Po0.05), the levels of p-JHK and p-p38 were not significantly changed and the levels of MMP-2 and MMP-9 were significantly downregulated (Po0.05). siRNA-targeting BMP-2 can markedly inhibited the expression of BMP-2 in liver cancer SMMC7721 cells, and decrease the abilities of migration and invasion of liver cancer cells, especially siRNA-B. The inhibitory effects of siRNA-B-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells may be caused by the downregulation of MMP-2 and MMP-9 through MAPK/ERK pathway, whereas is not related to MAPK/JNK and MAPK/p38 pathway.
Introduction
Liver cancer possesses powerful abilities of migration and invasion, which is a formidable problem in clinical treatment of liver cancer and a key factor to prognosis of liver cancer. Bone morphogenetic proteins (BMPs) are a group of functional proteins, which are widely involved in proliferation, differentiation and apoptosis of a variety of cells. BMPs not only can induce the differentiation of mesenchymal stem cells to bone-forming cells, but also can induce the formation of a variety of vasoactive factors and stimulate endothelial cell migration and neovascularization. 1 Cell migration is a biological basis of organ formation, and tumor invasion and metastasis. BMPs have an important role in tumor invasion and metastasis. Recent study has indicated a close correlation of high expression of BMPs with tumor formation and progression, especially BMP-2, and BMP-2 is likely to become a new target for tumor therapy. 2 Little research has been done about the effect of BMP-2 on migration and invasion of hepatic cancer cells. Therefore, we observed the effects of small interfering RNA (siRNA)-targeting BMP-2 on BMP-2 expression in SMMC7721 cells and on the abilities of migration and invasion of SMMC7721 cells and explored its mechanism, which provides a theoretical and experimental basis for further in-depth study about role of BMPs in occurrence and progression of human liver cancer.
Materials and methods

Reagents
Human liver cancer SMMC7721 cell lines were purchased from Shanghai Mesa Bio-Technology (Shanghai, China). Borden chamber and flow cytometer were from BD (Frankin, NJ). RPMI1640 medium was provided by HyClone (Logan, UT). Dimethyl sulfoxide was obtained from Sigma (St Louis, MO). Trypsin was from Beijing Solarbio (Beijing, China). Fetal calf serum was purchased from Hangzhou Sijiqing (Hangzhou, China). Trizol reagent was provided by Beijing Tiangen (Beijing, China). Lipofectamine 2000 was purchased from Invitrogen (Carlsbad, CA). RT kit was from Fermentas (Ontario, Canada). Mouse anti-human monoclonal antibody of BMP-2, rabbit anti-human polyclonal antibody of actin, p-ERK antibody, p-JNK antibody, p-p38 antibody, mouse anti-human monoclonal antibodies of MMP-2 and MMP-9 were provided by Santa Cruz (Santa Cruz, CA). Secondary antibodies of goat anti-mouse and goat anti-rabbit were purchased from Beijing Zhongshan Golden Bridge Bio (Beijing, China). Gel for western blot and device for electrophoresis were from Bio-Rad (Hercules, CA).
Cell recovery and culture SMMC7721 cells were taken from liquid nitrogen and thawed in 37 1C water bath. And then these cells were quickly placed in RPMI1640 medium containing 10% fetal calf serum to be incubated at 37 1C in a fully humidified atmosphere of 5% CO 2 until they grew to 90% densities, followed by passage using 0.25% trypsin at 37 1C under sterile condition.
Design and synthesis of sequences of siRNAs targeting BMP-2
The three pairs of sequences of siRNAs targeting BMP-2 were designed according to hBMP-2mRNA (NM_001200) published by GenBank, and human BMP-2 gene sequence and its secondary structure, and based on the design principles of siRNA made by Tuschl et al. 3 with web design software provided by Ambion (Austin, TX). These siRNAs were called BMP-2-siRNA-A, BMP-2-siRNA-B and BMP-2-siRNA-C and negative control was also designed. The transcription templates of siRNAs were synthesized by Guangzhou Borui Bioengineering (Guangzhou, China) and their sequences are shown in Table 1 .
Grouping and transfection
In this study, there were six groups including group I (normal control, non-transfected cells), group II (blank control, only liposome-transfected cells), group III (negative control, non-specific siRNA-transfected cells) and groups IV-VI (BMP-2-siRNA-A, BMP-2-siRNA-B and BMP-2-siRNA-C-transfected cells, respectively). Cells were adjusted to 2 Â 10 5 ml À1 , and inoculated in 6-well plate for 24 h. Cells whose density reached 70-80% fusion were used for transfection. Cells were incubated using 3 ml of serum-free RPMI1640 medium for 2 h followed by transfection according to instructions of kit, and then continued to be incubated for 48 h using RPMI1640 medium containing 10% fetal calf serum 6 h after transfection.
Determination of BMP-2 mRNA level using semi-quantitative PCR The total RNA was extracted using one-step. The primers of BMP-2 and control glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were synthesized by Guangzhou Ruibo Bio-engineering (Guangzhou, China). Detection of BMP-2 protein level using western blotting Pre-cooled 4 1C lysis buffer (volume of five times) was added in differently cultured cells, which had been washed using phosphate-buffered saline (PBS), then placed on ice for 20 min, and then centrifugated at a rate of 12 000 Â g and at 4 1C for 2 min. The supernatant solution was stored at À20 1C for future use. Protein concentration was determined using Bradford method. A total of 50 mg of sample per well underwent 12% SDS-polyacrylamide gel electrophoresis under non-reducing conditions, and then was transferred onto nitrocellulose membrane followed by sealing using 4 1C PBS containing 5 1C dried skim milk overnight. And then mouse anti-human antibody of BMP-2 (1:200) was added at room temperature for 2 h, following washing three times using 0.05% Tween-PBS, HRP-labeled goat anti-mouse Ig G (1:2000) was added for 2 h. The mixture was washed three times using 0.05% Tween-PBS and each time lasted 10 min. Finally, substrate electrochemiluminescence was added for visualization. Following gel electrophoresis image scanning, image analysis was performed with GAPDH as control. The relative content of BMP-2 protein was expressed as relative gray scales. Testing was performed in triplicate. BMP-2-siRNA-A Positive-sense strand:
Anti-sense strand:
Abbreviations: BMP, bone morphogenetic protein; siRNA, small interfering RNA.
Cell scratch test
Cells were inoculated in 6-well plate and transfected when their growth reached 70-80% fusion. And then these cells were incubated in a fully humidified atmosphere of 5% CO 2 at 37 1C for 6 h. A 2-cm scarification was made on the surface of cell culture using cell scraper in group I, III and V, followed by incubation using antibiotics-free RPMI1640 containing 10% fetal calf serum for 24 h. The width of cell scratch was measured under 200 Â phase-contrast microscope. Smaller width indicates stronger ability of migration. In each group, there were five parallel wells for testing (n ¼ 5).
In vitro invasion assay Cell invasion was assessed using 8 mm pore size Borden chamber (24-well plate). The upper chamber was washed using serum-free RPMI1640 medium two times, and then 50 ml of Matrigel (1:3) was added at 37 1C for 30 min to make artificial basement membrane. The upper chamber was loaded with 1 Â 10 5 cells of group I, III and V in a total volume of 200 ml and the lower chamber was loaded with 600 ml of serum-free RPMI 1640 medium containing 0.1% bovine serum albumin for incubation in a fully humidified atmosphere of 5% CO 2 at 37 1C for 24 h. The chamber was taken and liquid in the upper chamber was thrown away. The cells not to penetrate the membrane of the upper chamber were wiped out using cotton swabs. The cells to penetrate the membrane were fixed with methanol for 5 min, stained with Giemsa solution and mounted using neutral gun. The numbers of invasion of cells in five visual fields were counted under a light microscope and the mean was calculated. The invasive ability of tumor cells was expressed as the number of invasion of cells. Testing was performed in triplicate in each group.
Determining the protein levels of p-ERK, p-JNK, p-p38 and the protein levels of MMP-2 and MMP-9 using western blotting The protein levels of p-ERK, p-JNK and p-p38 and the protein levels of MMP-2 and MMP-9 in group I, III and V were determined 48 h after siRNA-B-targeting BMP-2 was transfected into liver cancer SMMC7721 cells. The procedures were similar to that in detection of BMP-2 protein level using western blotting, and the difference was that BMP-2 antibody was replaced by p-ERK, p-JNK, p-p38, MMP-2 and MMP-9 antibody.
Statistical treatment
Experimental data were analyzed using SPSS 13.0 software. Experimental data in each group were expressed as x ± s (mean ± s.d.). Single-factor analysis of variance was used for comparison among multiple groups. The t-test was used for comparison between two groups. Statistical significance was established at Po0.05.
Results
Effect of BMP-2 gene silencing on the expression of mRNA and protein of BMP-2 in SMMC7721 cells Reverse transcription-PCR) showed that there were GAPDH gene band at 825 bp and BMP-2 gene band at about 418 bp in each group 48 h after transfection of SMMC7721 cells (Figure 1) . The ratio of BMP-2 to GAPDH was obtained using spectrodensitometry and was 0.89±0.11, 0.93±0.12, 0.92±0.14, 0.65±0.08, 0.32±0.07 and 0.55±0.07 in group I-VI, respectively. The mRNA expression of BMP-2 was lower in group IV-VI than in group I-III (Po0.05), especially in group V, the mRNA expression was the lowest (Po0.01). However, there was no statically significant difference in mRNA expression between group I-III (P40.05), but group V had statistically significant difference compared with group IV and VI (Po0.05). The results of western blot are shown in Table 2 and Figure 2 . The relative gray scale of BMP-2 protein was significantly downregulated in group V (0.37 ± 0.10). In relative gray scale of BMP-2 protein, group V has significant difference compared with group IV and VI (P40.05), but there was no significant difference between group I-III (Po0.05). The results of western blot were consistent with that of reverse transcription-PCR.
Cell scratch test
To observe the effect of siRNA-targeting BMP-2 gene on the ability of migration of SMMC7721 cells, BMP-2-siRNA-B group that had the most obvious interference effect was selected to undergo cell scratch test and compared with normal control group and negative control group. The width of cell scratch was 65.8±5.3 mm, 36.6±4.0 mm and 34.1±5.1 mm in BMP-2-siRNA-B group, normal control group and negative control group, respectively. The results indicated that the ability of migration of liver cancer SMMC7721 cells was significantly decreased in BMP-2-siRNA-B group, and BMP-2-siRNA-B group had significant difference in the width of cell scratch compared with normal control group and negative control group (Po0.01, Figure 3 ).
In vitro invasion assay of Transwell chamber
To observe the effect of siRNA targeting BMP-2 gene on the ability of invasion of SMMC7721 cells, BMP-2-siRNA-B group that had the most obvious interference effect was selected to undergo in vitro invasion test of Transwell chamber (Corning Company, Corning, NY) and compared with normal control group and negative control group. The number of cells to penetrate Matrigel from Transwell upper chamber to Transwell lower chamber reflects the ability of cell invasion. Five visual fields in each group were randomly selected to count the number of invasion of cells. The number (mean þ s.d.) of cells to penetrate the membrane was (6.4 ± 3.6), (23.7±3.2) and (22.3±3.8) in BMP-2-siRNA-B group, normal control group and negative control group, respectively. The results indicated the ability of invasion of liver cancer SMMC7721 cells was significantly decreased after BMP-2-siRNA-B had mediated BMP-2 gene, and BMP-2-siRNA-B group had significant difference in the number of invasion of cells compared with normal control group and negative control group (Po0.05, Figure 4) . Levels of p-ERK, p-JNK and p-p38 and the levels of MMP-2 and MMP-9 determined with western blot Western blotting indicated that the protein level of p-ERK was significantly lower in group V than in group I and III (Po0.05, Figure 5 and Table 3 ), the protein levels of p-JNK and p-p38 were not significantly changed ( Figure 5 and Table 3) , and the protein levels of MMP-2 and MMP-9 were significantly lower in group V than in group I and III (Po0.05, Figure 6 and Table 3 ).
Discussion
BMPs are a group of functional proteins, which are widely involved in proliferation, differentiation and apoptosis of a variety of cells. It can induce the migration and differentiation of precursor cells, regulate cellular growth, proliferation and migration, and control selfrenewal of embryonic stem cells. In recent years, the correlation of BMP-2, an important molecule in gene regulation, with diseases, particularly with neoplasms has become a focus in biomedical field. BMPs not only can induce the differentiation of mesenchymal stem cells to bone-forming cells, but also can induce the formation of a variety of vasoactive factors and stimulate endothelial cell migration and neovascularization. 1 BMPs have an important role in invasion and metastasis of tumors, which has been confirmed by many studies. Langenfeld et al. 4 found that the expression of BMP-2 was high in lung cancer A549 cells and the abilities of migration and invasion of lung cancer A549 cells were increased. Bush et al. 5 also found that BMP-2 might increase the invasiveness of melanoma B16-F1 cells, whereas natural antagonist-noggin could block tumor invasion and formation. Rothhammer et al. 6 reported that BMP-4 might significantly promote the abilities of migration and invasion of melanoma cells. Montesano 7 has discovered that when the concentration of BMP-4 is 1-10 ng ml À1 , BMP-4 can induce outward invasive growth of epithelial cells of breast; when BMP-4 is 20-100 ng ml
À1
, BMP-4 can lead to the fracture of cell-cell adhesions, which makes cells disperse and enter surrounding collagen matrix, resulting in metastasis of breast cancer. Deng et al. 8 have believed that the overexpression of BMP-4 can be against serum starvation-induced apoptosis and increase their abilities of migration and invasion. Langenfeld et al. 9 have found that BMP-2 can significantly increase angiogenesis in neoplasm formed with A549 cells in nude mice, confirming that BMP-2 promotes tumor growth by stimulating angiogenesis. Darby et al. 10 have reported that BMP-6 is not markedly related to the proliferation of prostate cancer PC3M and DU145 cells, but significantly increases cellular migration and invasion, and elevates the phosphorylation levels of metalloproteinase MMP-2 and MMP-9 mRNAs as well as MAPK. Piccirillo et al. 11 have described that BMP-BMPR signaling system controls the activities of normal brain stem cells and has a key inhibitory role in early formation of malignant glioma. BMPs may be used as a new target of non-cytotoxic therapy for human malignant glioma. However, little research has been done about the effect of BMP-2 on migration and invasion of hepatic cancer cells so far.
In the previous study, we determined the expression levels of BMP-2 in normal liver tissue and liver cancer tissue using semi-quantitative reverse transcription-PCR and western blot, and found that the levels of mRNA and protein of BMP-2 were greater in liver cancer tissue than in normal liver tissue, suggesting that BMP-2 is closely related to liver cancer, but specific biological mechanism is unclear. 13 In this study, the molecular sequences of three siRNAs targeting BMP-2 gene were designed, synthesized and transfected into SMMC7721 cells using lipofectamine method. The effects of BMP-2 gene silencing on the abilities of migration and invasion of human liver cancer 
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MMP-9 92kDa GAPDH 43kDa Figure 6 Determination of protein level of MMP-2 and MMP-9 using western blot in groups I, III and V. 1, normal control; 2, negative control; 3, BMP-2-siRNA-B group.
SMMC7721 cells were explored with scratch test and in vitro invasion assay. Results indicated that the width of cell scratch was 65.8 ± 5.3 mm, 36.6 ± 4.0 mm and 34.1±5.1 mm in BMP-2-siRNA-B group, normal control group and negative control group, respectively. Compared with normal control group and negative control group, BMP-2-siRNA-B group had significant difference in width of cell scratch (Po0.01), suggesting that the ability of migration of liver cancer SMMC7721 cells was significantly decreased after BMP-2 gene silencing.
In vitro invasion assay showed that the number of cells to penetrate the membrane was (6.4 ± 3.6), (23.7 ± 3.2) and (22.3±3.8) in BMP-2-siRNA-B group, normal control group and negative control group, respectively. Compared with normal control group and negative control group, BMP-2-siRNA-B group had significant difference in the number of invasion of cells (Po0.05), demonstrating that the ability of invasion of liver cancer SMMC7721 cells was significantly decreased after BMP-2 gene silencing. To investigate the mechanism that siRNAs targeting BMP-2 gene inhibits the abilities of migration and invasion of human liver cancer SMMC7721 cells, the levels of p-ERK, p-JNK and p-p38 and the levels of MMP-2 and MMP-9 in BMP-2-siRNA-B group, normal control group and negative control group were evaluated with western blot 48 h after siRNA-B-targeting BMP-2 was transfected into liver cancer SMMC7721 cells.
Results indicated that compared with normal control group and negative control group, the level of p-ERK was significantly decreased, the levels of p-JHK and p-p38 were not significantly changed and the levels of MMP-2 and MMP-9 were significantly downregulated in BMP-2-siRNA-B group (Po0.05; Figures 5 and 6; Table 3 ).
The above results indicate that the inhibitory effects of siRNA-B-targeting BMP-2 on the abilities of migration and invasion of human liver cancer SMMC7721 cells may be caused by the downregulation of MMP-2 and MMP-9 through MAPK/ERK pathway, whereas is not related to MAPK/JNK and MAPK/p38 pathway.
